For years, payment integrity was built around simple assumptions: errors can be fixed after payment. In today’s environment of rising medical costs and accelerating claims volume, that approach isn’t sustainable.
At the annual Medicarians conference in Las Vegas on Monday, an analyst on Medicare Advantage policy research sounded the alarm about how there’s a fundamental shift in attitude towards MA
Eli Lilly is expanding its reach in genetic medicines with a multi-billion dollar deal to acquire Kelonia Therapeutics, a startup whose most advanced drug candidate is a cell therapy in
Workplace violence is a persistent and worsening problem in healthcare. According to the Bureau of Labor Statistics, healthcare workers are five times more likely to experience workplace violence than those
Obsidian Therapeutics is merging with Galera Therapeutics to advance clinical development of a pipeline led by a next-generation cell therapy for melanoma that could offer advantages over the only cell
In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s board of directors when the vaccine maker announced a billion-dollar deal with
Across the country, nurse leaders are rethinking how care is delivered and what it means to lead through transformation. The past few years have shown us that traditional nursing models
Most of what we called healthcare innovation over the last decade was an expensive lie we told ourselves. Between 2015 and 2020, we poured billions into digitizing the status quo,
In a cell, the nucleus and related genetic material are housed inside a double-layered membrane. Scientists previously thought this nuclear envelope played a passive role, simply separating these components from
The challenges facing social security are no secret. They are straining global systems built for a different era. According to the International Labour Organization’s World Social Protection Report 2024-26, a staggering 3.8 billion
